美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=METFORMIN HYDROCHLORIDE"
符合检索条件的记录共 397 条
共 20 页，当前第 16 页
首页 上一页 下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 212198 003 ANDA EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 12.5MG;500MG No No 2022/07/07 2022/07/07 ZYDUS PHARMS Discontinued
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 212198 004 ANDA EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 12.5MG;1GM No No 2022/07/07 2022/07/07 ZYDUS PHARMS Discontinued
DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE 211583 001 ANDA DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 2.5MG/1000MG No No 2022/08/03 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE 211583 002 ANDA DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG/500MG No No 2022/08/03 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE 211583 003 ANDA DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG/1000MG No No 2022/08/03 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE 211583 004 ANDA DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG/500MG No No 2022/08/03 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE 211583 005 ANDA DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG/1000MG No No 2022/08/03 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
METFORMIN HYDROCHLORIDE 212677 001 ANDA METFORMIN HYDROCHLORIDE SOLUTION;ORAL 500MG/5ML No No 2022/08/19 2022/08/19 VISTAPHARM LLC Prescription
METFORMIN HYDROCHLORIDE 212448 001 ANDA METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 500MG No No 2023/01/10 2023/01/10 MICRO LABS Prescription
METFORMIN HYDROCHLORIDE 212448 002 ANDA METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 1GM No No 2023/01/10 2023/01/10 MICRO LABS Prescription
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE 212362 001 ANDA EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 5MG/1000MG No No 2023/01/31 (TA) -- MSN LABS PVT LTD None (Tentative Approval)
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE 212362 002 ANDA EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 10MG/1000MG No No 2023/01/31 (TA) -- MSN LABS PVT LTD None (Tentative Approval)
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE 212362 003 ANDA EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 12.5MG/1000MG No No 2023/01/31 (TA) -- MSN LABS PVT LTD None (Tentative Approval)
EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE 212362 004 ANDA EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 25MG/1000MG No No 2023/01/31 (TA) -- MSN LABS PVT LTD None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE 210542 001 ANDA CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET;ORAL 50MG;500MG No No 2023/02/16 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE 210542 002 ANDA CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET;ORAL 50MG;1000MG No No 2023/02/16 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE 210542 003 ANDA CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET;ORAL 150MG;500MG No No 2023/02/16 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE 210542 004 ANDA CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE TABLET;ORAL 150MG;1000MG No No 2023/02/16 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE 208449 001 ANDA LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 2.5MG;500MG No No 2023/03/30 2023/03/30 ZYDUS PHARMS Prescription
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE 208449 002 ANDA LINAGLIPTIN; METFORMIN HYDROCHLORIDE TABLET;ORAL 2.5MG;850MG No No 2023/03/30 2023/03/30 ZYDUS PHARMS Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2025 DrugFuture->U.S. FDA Drugs Database